Analgesic

PreclinicalSmall molecule

CCeren Melahat Donmezer

Analgesic is one of 65 small molecule programs targeting Cerebral Palsy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cerebral PalsyActive, not recruiting

Clinical Efficacy and SafetyActive, not recruiting

FunctionCompleted

Cerebral PalsyPreclinical

Active, not recruiting

Clinical Efficacy and SafetyPreclinical

Active, not recruiting

FunctionPreclinical

Completed

Competition

Competitive Landscape

55 competitors in Function

#DrugCompanyPhaseTrials

Indocin

CCosette Pharmaceuticals, Inc.

Approved

3 2

Flomax

Sanofi

Phase 3

1 3

Taxol

Teva

Phase 2

1 4

N-Acetyl Cyteien

SStanford University

Phase 3

2 5

Ezallor Sprinkle

AstraZeneca

Phase 2

1 6

Tuoyi

CCoherus Oncology, Inc.

Phase 2

1 7

Xeljanz

PPrism Pharmaceuticals

Phase 2

1 8

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 2

1 9

Paraplatin

AAvyxa

Phase 2

1 10

Golytely

Bayer

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

N/AActive, not recruiting

Clinical Efficacy and Safety

NCT06344403

Clinical

Trials by Indication[1]

Third Molar Surgery2 trials

Investigation of Effectiveness of Local Antibiotic With Platelet Rich Fibrin on Third Molar Surgery Outcomes In Vivo

Completed·CCeren Melahat Donmezer··NCT05678296·60 enrolled

Comperasion the Postoperative Effect of Low Laser Therapy and Platelet Rich Fibrin on Mandibular Third Molar Surgery.

Completed·BBeste Erismen··NCT06262945·60 enrolled

Function1 trial

Manual Therapy and Kinesio Taping on Temporomandibular Joint Dysfunction Following Oral Surgeries

Completed·—·N/A·NCT05422703·30 enrolled

Clinical Efficacy and Safety1 trial

Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated Pain

Active, not recruiting·—·N/A·NCT06344403·136 enrolled

Endometrial1 trial

Optimizing Analgesia for Endometrial Biopsy

Completed·GGaziosmanpasa Research and Education Hospital·Phase 4·NCT06540599·197 enrolled

Antibiotics1 trial

Comparison The Postoperative Effects of Local and Systemic Antibiotics Applied With Platelets Rich Fibrin

Completed·CCeren Melahat Donmezer··NCT04989127·75 enrolled

2 more indications

Postherpetic Neuralgia1 trial

Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain

Completed·GGrünenthal GmbH·Phase 3·NCT00414349·431 enrolled

Cerebral Palsy1 trial

Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump

Completed·UUniversity of Colorado, Denver·N/A·NCT00884650·54 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Analgesic. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Analgesic compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Analgesic. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ceren Melahat Donmezer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CCeren Melahat Donmezer

Analgesic

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Third Molar Surgery2 trials

Function1 trial

Clinical Efficacy and Safety1 trial

Endometrial1 trial

Antibiotics1 trial

Postherpetic Neuralgia1 trial

Cerebral Palsy1 trial

References

Drug Info

Quick Facts

Related News